• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏α-半乳糖苷酶 A 的大鼠会积累糖脂,并表现出法布瑞病的心脏肾脏表型。

α-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease.

机构信息

Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.

出版信息

FASEB J. 2019 Jan;33(1):418-429. doi: 10.1096/fj.201800771R. Epub 2018 Jul 6.

DOI:10.1096/fj.201800771R
PMID:29979634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6629127/
Abstract

Fabry disease is an X-linked lysosomal storage disease caused by α-galactosidase A (α-Gal A) deficiency. Kidney and heart failure are frequent complications in adulthood and greatly contribute to patient morbidity and mortality. Because α-Gal A-deficient mouse models do not recapitulate cardiorenal findings observed in patients, a nonmouse model may be beneficial to our understanding of disease pathogenesis. In this study, we evaluated disease processes in a recently generated Fabry rat model. We found that male Fabry rats weighed significantly less than wild-type (WT) males, whereas female Fabry rats weighed significantly more than WT females. Whereas no difference in female survival was detected, we observed that male Fabry rats had a decreased lifespan. Skin histology revealed that inflammation and lipoatrophy may be chief disease mediators in patients. With respect to the kidney and heart, we found that both organs accumulate α-Gal A substrates, including the established biomarkers, globotriaosylceramide and globotriaosylsphingosine. Longitudinal serum and urine chemistry panels demonstrated pronounced renal tubule dysfunction, which was confirmed histologically. Mitral valve thickening was observed in Fabry rats using echocardiography. We conclude that Fabry rats recapitulate important kidney and heart phenotypes experienced by patients and can be further used to study disease mechanisms and test therapies.-Miller, J. J., Aoki, K., Mascari, C. A., Beltrame, A. K., Sokumbi, O., North, P. E., Tiemeyer, M., Kriegel, A. J., Dahms, N. M., α-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease.

摘要

法布里病是一种 X 连锁溶酶体贮积病,由α-半乳糖苷酶 A(α-Gal A)缺乏引起。肾脏和心力衰竭是成年期常见的并发症,极大地增加了患者的发病率和死亡率。由于缺乏α-Gal A 的小鼠模型不能重现患者中观察到的心肾发现,因此非小鼠模型可能有助于我们了解疾病的发病机制。在这项研究中,我们评估了最近生成的法布里大鼠模型中的疾病过程。我们发现,雄性法布里大鼠的体重明显低于野生型(WT)雄性大鼠,而雌性法布里大鼠的体重明显高于 WT 雌性大鼠。虽然未发现雌性生存率的差异,但我们观察到雄性法布里大鼠的寿命缩短。皮肤组织学显示,炎症和脂肪萎缩可能是患者的主要疾病介质。就肾脏和心脏而言,我们发现这两个器官都积累了α-Gal A 底物,包括已建立的生物标志物,神经节苷脂和神经节苷脂鞘氨醇。纵向血清和尿液化学小组表明,存在明显的肾小管功能障碍,这在组织学上得到了证实。使用超声心动图观察到法布里大鼠的二尖瓣增厚。我们得出结论,法布里大鼠重现了患者经历的重要肾脏和心脏表型,并且可以进一步用于研究疾病机制和测试疗法。-米勒,J. J.,青木,K.,马斯卡里,C. A.,贝尔特拉梅,A. K.,索昆比,O.,北,P. E.,蒂梅耶,M.,克里格尔,A. J.,达姆斯,N. M.,α-半乳糖苷酶 A 缺乏的大鼠积累糖脂并发展法布里病的心脏肾脏表型。

相似文献

1
α-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease.缺乏α-半乳糖苷酶 A 的大鼠会积累糖脂,并表现出法布瑞病的心脏肾脏表型。
FASEB J. 2019 Jan;33(1):418-429. doi: 10.1096/fj.201800771R. Epub 2018 Jul 6.
2
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease.缺乏α-半乳糖苷酶 A 的大鼠会出现法布里病的眼部表现。
Sci Rep. 2019 Jun 28;9(1):9392. doi: 10.1038/s41598-019-45837-1.
3
Neuropathic pain in a Fabry disease rat model.法布里病大鼠模型中的神经性疼痛。
JCI Insight. 2018 Mar 22;3(6):99171. doi: 10.1172/jci.insight.99171.
4
Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy.法布里病小鼠模型中葡萄糖脑苷脂的减少:成功的酶替代治疗的纠正。
Gene. 2014 Feb 15;536(1):97-104. doi: 10.1016/j.gene.2013.11.073. Epub 2013 Dec 13.
5
Platelet and myeloid cell phenotypes in a rat model of Fabry disease.法布瑞氏病大鼠模型中的血小板和髓细胞表型。
FASEB J. 2021 Aug;35(8):e21818. doi: 10.1096/fj.202001727RR.
6
Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.长期酶替代疗法可减少 Fabry 病女性患者的蛋白尿并保护近端肾小管功能。
Nephrol Dial Transplant. 2014 Mar;29(3):619-25. doi: 10.1093/ndt/gft452. Epub 2013 Nov 8.
7
Therapeutic Strategy for Fabry Disease by Intravenous Administration of Adeno-Associated Virus 9 in a Symptomatic Mouse Model.腺相关病毒 9 静脉注射治疗症状性 Fabry 病小鼠模型的治疗策略。
Hum Gene Ther. 2024 Mar;35(5-6):192-201. doi: 10.1089/hum.2023.106.
8
Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.α-半乳糖苷酶A基因敲除小鼠(法布里病模型)中球三糖基神经酰胺异构体、球三糖基鞘氨醇及其类似物的分布
PLoS One. 2015 Dec 14;10(12):e0144958. doi: 10.1371/journal.pone.0144958. eCollection 2015.
9
Tetrahydrobiopterin deficiency in the pathogenesis of Fabry disease.四氢生物蝶呤缺乏在法布里病发病机制中的作用
Hum Mol Genet. 2017 Mar 15;26(6):1182-1192. doi: 10.1093/hmg/ddx032.
10
The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women.血管糖脂储存与法布里病临床表现的关系:对大量临床受累杂合子女性队列的横断面研究。
Medicine (Baltimore). 2005 Sep;84(5):261-268. doi: 10.1097/01.md.0000178976.62537.6b.

引用本文的文献

1
DANGO: An MS data annotation tool for glycolipidomics.DANGO:一种用于糖脂组学的质谱数据注释工具。
BBA Adv. 2025 Apr 27;7:100161. doi: 10.1016/j.bbadva.2025.100161. eCollection 2025.
2
Human in vitro models for Fabry disease: new paths for unravelling disease mechanisms and therapies.人源法布里病体外模型:解析疾病机制和治疗方法的新途径。
J Transl Med. 2024 Oct 24;22(1):965. doi: 10.1186/s12967-024-05756-w.
3
Fucosylation of glycoproteins and glycolipids: opposing roles in cholera intoxication.糖蛋白和糖脂的岩藻糖基化:在霍乱毒素中毒中的相反作用。
Nat Chem Biol. 2025 Apr;21(4):555-566. doi: 10.1038/s41589-024-01748-5. Epub 2024 Oct 16.
4
Fabry disease Schwann cells release p11 to induce sensory neuron hyperactivity.法布里病施万细胞释放 p11 诱导感觉神经元过度活跃。
JCI Insight. 2024 Mar 7;9(8):e172869. doi: 10.1172/jci.insight.172869.
5
The role of tubular cells in the pathogenesis of Fabry nephropathy.肾小管细胞在法布里肾病发病机制中的作用。
Front Cardiovasc Med. 2024 Apr 5;11:1386042. doi: 10.3389/fcvm.2024.1386042. eCollection 2024.
6
Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.安德森-法布里病中枢及周围神经系统并发症的分子发病机制。
Int J Mol Sci. 2023 Dec 20;25(1):61. doi: 10.3390/ijms25010061.
7
Fucosylated glycoproteins and fucosylated glycolipids play opposing roles in cholera intoxication.岩藻糖基化糖蛋白和岩藻糖基化糖脂在霍乱中毒中发挥相反作用。
bioRxiv. 2023 Aug 3:2023.08.02.551727. doi: 10.1101/2023.08.02.551727.
8
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy.α-突触核蛋白的积累介导法布里肾病中的足细胞损伤。
J Clin Invest. 2023 Jun 1;133(11):e157782. doi: 10.1172/JCI157782.
9
Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease.法舒地尔可减轻血管内皮功能障碍和法布瑞病的多种表型。
Mol Ther. 2023 Apr 5;31(4):1002-1016. doi: 10.1016/j.ymthe.2023.02.003. Epub 2023 Feb 8.
10
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders.用于酶替代治疗和其他溶酶体贮积症治疗的聚合物药物递送系统。
Adv Drug Deliv Rev. 2023 Jun;197:114683. doi: 10.1016/j.addr.2022.114683. Epub 2023 Jan 16.

本文引用的文献

1
Neuropathic pain in a Fabry disease rat model.法布里病大鼠模型中的神经性疼痛。
JCI Insight. 2018 Mar 22;3(6):99171. doi: 10.1172/jci.insight.99171.
2
Contribution of inflammatory pathways to Fabry disease pathogenesis.炎症通路在法布瑞病发病机制中的作用。
Mol Genet Metab. 2017 Nov;122(3):19-27. doi: 10.1016/j.ymgme.2017.09.004. Epub 2017 Sep 13.
3
Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience.伊利诺伊州溶酶体贮积症的新生儿筛查:最初15个月的经验
J Pediatr. 2017 Nov;190:130-135. doi: 10.1016/j.jpeds.2017.06.048. Epub 2017 Jul 17.
4
Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy.法布里病患者尿足细胞丢失增加,且与法布里肾病的临床严重程度相关。
PLoS One. 2016 Dec 16;11(12):e0168346. doi: 10.1371/journal.pone.0168346. eCollection 2016.
5
Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.使用串联质谱法对六种溶酶体贮积症进行新生儿筛查的初步研究。
Mol Genet Metab. 2016 Aug;118(4):304-9. doi: 10.1016/j.ymgme.2016.05.015. Epub 2016 May 20.
6
Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development.聚焦感觉系统和疼痛发展,对法布里病α-半乳糖苷酶A缺陷小鼠模型进行全面和差异化的长期表征。
Mol Pain. 2016 May 4;12. doi: 10.1177/1744806916646379. Print 2016.
7
The awesome lysosome.了不起的溶酶体。
EMBO Mol Med. 2016 Feb 1;8(2):73-6. doi: 10.15252/emmm.201505966.
8
Symbol Nomenclature for Graphical Representations of Glycans.聚糖图形表示的符号命名法。
Glycobiology. 2015 Dec;25(12):1323-4. doi: 10.1093/glycob/cwv091.
9
Lyso-Gb3 activates Notch1 in human podocytes.溶血神经节苷脂三己糖苷(Lyso-Gb3)激活人足细胞中的Notch1。
Hum Mol Genet. 2015 Oct 15;24(20):5720-32. doi: 10.1093/hmg/ddv291. Epub 2015 Jul 23.
10
Substrate-specific gene expression profiles in different kidney cell types are associated with Fabry disease.不同肾细胞类型中的底物特异性基因表达谱与法布里病相关。
Mol Med Rep. 2015 Oct;12(4):5049-57. doi: 10.3892/mmr.2015.4010. Epub 2015 Jul 1.